-
1
-
-
0032493043
-
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
-
A. Carr, K. Samaras, and S. Burton A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 1998 F51 F58
-
(1998)
AIDS
, vol.12
-
-
Carr, A.1
Samaras, K.2
Burton, S.3
-
2
-
-
0032554569
-
"Buffalo hump" in men with HIV-1 infection
-
J.C. Lo, K. Mulligan, and V.W. Tai "Buffalo hump" in men with HIV-1 infection Lancet 351 1998 867 870
-
(1998)
Lancet
, vol.351
, pp. 867-870
-
-
Lo, J.C.1
Mulligan, K.2
Tai, V.W.3
-
3
-
-
0012570692
-
Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study
-
T. Saint-Marc, M. Partisani, and I. Poizot-Martin Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study AIDS 14 2000 37 49
-
(2000)
AIDS
, vol.14
, pp. 37-49
-
-
Saint-Marc, T.1
Partisani, M.2
Poizot-Martin, I.3
-
4
-
-
2942684780
-
Pathogenesis of the HAART-associated metabolic syndrome: A model of "systemic steatosis"
-
A. Balasubramanyam, F. Jahoor, P. Jones, R.V. Sekhar, and H.J. Pownall Pathogenesis of the HAART-associated metabolic syndrome: a model of "systemic steatosis" Curr Opin Lipidol 15 2004 59 67
-
(2004)
Curr Opin Lipidol
, vol.15
, pp. 59-67
-
-
Balasubramanyam, A.1
Jahoor, F.2
Jones, P.3
Sekhar, R.V.4
Pownall, H.J.5
-
5
-
-
79956126364
-
Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: Novel insights into pathophysiology and emerging opportunities for treatment
-
F. Magkos, and C.S. Mantzoros Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment Metabolism 60 2011 749 753
-
(2011)
Metabolism
, vol.60
, pp. 749-753
-
-
Magkos, F.1
Mantzoros, C.S.2
-
6
-
-
0034631873
-
Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: A 5-year cohort study
-
S. Tsiodras, C. Mantzoros, S. Hammer, and M. Samore Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study Arch Intern Med 160 2000 2050 2056
-
(2000)
Arch Intern Med
, vol.160
, pp. 2050-2056
-
-
Tsiodras, S.1
Mantzoros, C.2
Hammer, S.3
Samore, M.4
-
7
-
-
0033391005
-
A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy
-
T. Saint-Marc, M. Partisani, and I. Poizot-Martin A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy AIDS 13 1999 1659 1667
-
(1999)
AIDS
, vol.13
, pp. 1659-1667
-
-
Saint-Marc, T.1
Partisani, M.2
Poizot-Martin, I.3
-
8
-
-
0033521686
-
The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor
-
T. Kino, A. Gragerov, and J.B. Kopp The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor J Exp Med 189 1999 51 62
-
(1999)
J Exp Med
, vol.189
, pp. 51-62
-
-
Kino, T.1
Gragerov, A.2
Kopp, J.B.3
-
9
-
-
0026065576
-
Serum triglyceride and coronary heart disease
-
M.A. Austin Serum triglyceride and coronary heart disease Aterioscler Thromb 11 1991 2 14
-
(1991)
Aterioscler Thromb
, vol.11
, pp. 2-14
-
-
Austin, M.A.1
-
11
-
-
21944450979
-
Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome
-
R.V. Sekhar, F. Jahoor, and H.J. Pownall Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome Am J Clin Nutr 81 2005 1405 1410
-
(2005)
Am J Clin Nutr
, vol.81
, pp. 1405-1410
-
-
Sekhar, R.V.1
Jahoor, F.2
Pownall, H.J.3
-
12
-
-
0027275449
-
Serum cholesteryl ester transfer protein
-
A.R. Tall Serum cholesteryl ester transfer protein J Lipid Res 34 1993 1255 1274
-
(1993)
J Lipid Res
, vol.34
, pp. 1255-1274
-
-
Tall, A.R.1
-
13
-
-
0034746490
-
Proatherogenic role of elevated cholesteryl ester transfer from HDL to VLDL1 and dense LDL in type 2 diabetes: Impact of the degree of triglyceridemia
-
M. Guerin, W. Le Goff, and T.S. Lassel Proatherogenic role of elevated cholesteryl ester transfer from HDL to VLDL1 and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia Arterioscler Thromb Vasc Biol 21 2001 282 288
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 282-288
-
-
Guerin, M.1
Le Goff, W.2
Lassel, T.S.3
-
14
-
-
0029916607
-
Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with noninsulin-dependent diabetes mellitus
-
D. Bhatnagar, P.N. Durrington, and S. Kumar Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with noninsulin-dependent diabetes mellitus Diabet Med 13 1995 139 144
-
(1995)
Diabet Med
, vol.13
, pp. 139-144
-
-
Bhatnagar, D.1
Durrington, P.N.2
Kumar, S.3
-
15
-
-
0032171437
-
Elevated plasma cholesteryl ester transfer in NIDDM: Relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein
-
S. Riemens, A. van Tol, W. Sluiter, and R.P.F. Dullaart Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein Atherosclerosis 140 1998 71 79
-
(1998)
Atherosclerosis
, vol.140
, pp. 71-79
-
-
Riemens, S.1
Van Tol, A.2
Sluiter, W.3
Dullaart, R.P.F.4
-
16
-
-
0035021878
-
Effect of intensive lipid lowering strategy on low density lipoprotein particle size in patients with type 2 diabetes mellitus
-
S.D. Niemeijer-Kanters, G.M. Dalliga-Thie, and F.C. Rruijter-Heijstek Effect of intensive lipid lowering strategy on low density lipoprotein particle size in patients with type 2 diabetes mellitus Atherosclerosis 156 2001 209 216
-
(2001)
Atherosclerosis
, vol.156
, pp. 209-216
-
-
Niemeijer-Kanters, S.D.1
Dalliga-Thie, G.M.2
Rruijter-Heijstek, F.C.3
-
17
-
-
0032917836
-
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid composition of high-density and low-density lipoproteins
-
H.J. Pownall, D. Brauchi, and C. Kilinc Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid composition of high-density and low-density lipoproteins Atherosclerosis 143 1999 285 297
-
(1999)
Atherosclerosis
, vol.143
, pp. 285-297
-
-
Pownall, H.J.1
Brauchi, D.2
Kilinc, C.3
-
18
-
-
0027716650
-
Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus
-
J.D. Bagdade, J.T. Lane, and P.V. Subbaiah Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus Atherosclerosis 104 1-2 1993 69 77
-
(1993)
Atherosclerosis
, vol.104
, Issue.12
, pp. 69-77
-
-
Bagdade, J.D.1
Lane, J.T.2
Subbaiah, P.V.3
-
19
-
-
79960088422
-
Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on ART: Results of Heart Positive, a randomized, controlled study
-
A. Balasubramanyam, I. Coraza, E.O. Smith, L.W. Scott, P. Patel, and D. Iyer Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on ART: results of Heart Positive, a randomized, controlled study J Clin Endocrinol Metab 96 2011 2236 2247
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 2236-2247
-
-
Balasubramanyam, A.1
Coraza, I.2
Smith, E.O.3
Scott, L.W.4
Patel, P.5
Iyer, D.6
-
20
-
-
34848856661
-
Ten-year predicted coronary heart disease risk in HIV-infected men and women
-
R.C. Kaplan, L.A. Kingsley, A.R. Sharrett, X. Li, J. Lazar, and P.C. Tien Ten-year predicted coronary heart disease risk in HIV-infected men and women Clin Infect Dis 45 8 2007 1074 1081
-
(2007)
Clin Infect Dis
, vol.45
, Issue.8
, pp. 1074-1081
-
-
Kaplan, R.C.1
Kingsley, L.A.2
Sharrett, A.R.3
Li, X.4
Lazar, J.5
Tien, P.C.6
-
21
-
-
34250671221
-
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
-
V.A. Triant, H. Lee, C. Hadigan, and S.K. Grinspoon Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endocrinol Metab 92 7 2007 2506 2512
-
(2007)
J Clin Endocrinol Metab
, vol.92
, Issue.7
, pp. 2506-2512
-
-
Triant, V.A.1
Lee, H.2
Hadigan, C.3
Grinspoon, S.K.4
-
22
-
-
77952490522
-
Elevated risks of death for diabetes mellitus and cardiovascular diseases in Italian AIDS cases
-
D. Serraino, S. Bruzzone, A. Zucchetto, B. Suligoi, A. De Paoli, and S. Pennazza Elevated risks of death for diabetes mellitus and cardiovascular diseases in Italian AIDS cases AIDS Res Ther. 7 1 2010 11
-
(2010)
AIDS Res Ther.
, vol.7
, Issue.1
, pp. 11
-
-
Serraino, D.1
Bruzzone, S.2
Zucchetto, A.3
Suligoi, B.4
De Paoli, A.5
Pennazza, S.6
-
23
-
-
0142039928
-
Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP)
-
V.M. Paromov, and R.E. Morton Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP) J Biol Chem 278 42 2003 40859 40866
-
(2003)
J Biol Chem
, vol.278
, Issue.42
, pp. 40859-40866
-
-
Paromov, V.M.1
Morton, R.E.2
-
24
-
-
0028235946
-
Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: Selective inhibition among lipoprotein classes
-
R.E. Morton, and D.J. Greene Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes J Lipid Res 35 5 1994 836 847
-
(1994)
J Lipid Res
, vol.35
, Issue.5
, pp. 836-847
-
-
Morton, R.E.1
Greene, D.J.2
-
25
-
-
0034534981
-
Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity
-
T. Gautier, D. Masson, J.P. de Barros, A. Athias, P. Gambert, and D. Aunis Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity J Biol Chem 275 48 2000 37504 37509
-
(2000)
J Biol Chem
, vol.275
, Issue.48
, pp. 37504-37509
-
-
Gautier, T.1
Masson, D.2
De Barros, J.P.3
Athias, A.4
Gambert, P.5
Aunis, D.6
-
26
-
-
45249102216
-
HIV infection and high density lipoprotein metabolism
-
H. Rose, J. Hoy, and I. Woolley HIV infection and high density lipoprotein metabolism Atherosclerosis 199 2008 79 86
-
(2008)
Atherosclerosis
, vol.199
, pp. 79-86
-
-
Rose, H.1
Hoy, J.2
Woolley, I.3
-
27
-
-
0030481639
-
Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia
-
B. Föger, A. Ritsch, A. Doblinger, H. Wessels, and J.R. Patsch Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler Thromb Vasc Biol 16 1996 1430 1436
-
(1996)
Arterioscler Thromb Vasc Biol
, vol.16
, pp. 1430-1436
-
-
Föger, B.1
Ritsch, A.2
Doblinger, A.3
Wessels, H.4
Patsch, J.R.5
-
28
-
-
0345151837
-
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study
-
D. Periard, A. Telenti, and P. Sudre Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation 100 1999 700 705
-
(1999)
Circulation
, vol.100
, pp. 700-705
-
-
Periard, D.1
Telenti, A.2
Sudre, P.3
-
29
-
-
0033583977
-
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
-
A. Carr, K. Samaras, A. Thorisdottir, G.R. Kaufmann, D.J. Chisholm, and D.A. Cooper Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study Lancet 353 1999 2093 2099
-
(1999)
Lancet
, vol.353
, pp. 2093-2099
-
-
Carr, A.1
Samaras, K.2
Thorisdottir, A.3
Kaufmann, G.R.4
Chisholm, D.J.5
Cooper, D.A.6
-
31
-
-
0036740351
-
Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy
-
C. Hadigan, S. Borgonha, and J. Rabe Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy Metabolism 51 2002 1143 1147
-
(2002)
Metabolism
, vol.51
, pp. 1143-1147
-
-
Hadigan, C.1
Borgonha, S.2
Rabe, J.3
-
32
-
-
73749085891
-
Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men
-
L.J. Ware, A.G. Jackson, and S.A. Wootton Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men Br J Nutr 102 7 2009 1038 1046
-
(2009)
Br J Nutr
, vol.102
, Issue.7
, pp. 1038-1046
-
-
Ware, L.J.1
Jackson, A.G.2
Wootton, S.A.3
-
33
-
-
33751062798
-
Human immunodeficiency virus impairs reverse cholesterol transport from macrophages
-
e365
-
Z. Mujawar, H. Rose, and M. Morrow Human immunodeficiency virus impairs reverse cholesterol transport from macrophages PLoS Biol 4 11 2006 1970 1983 e365
-
(2006)
PLoS Biol
, vol.4
, Issue.11
, pp. 1970-1983
-
-
Mujawar, Z.1
Rose, H.2
Morrow, M.3
-
34
-
-
28444483137
-
HIV infection and high-density lipoprotein: The effect of the disease vs the effect of treatment
-
H. Rose, I. Woolley, and J. Hoy HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment Metabolism 55 1 2006 90 95
-
(2006)
Metabolism
, vol.55
, Issue.1
, pp. 90-95
-
-
Rose, H.1
Woolley, I.2
Hoy, J.3
|